Further, silencing hepatitis B X interacting protein (HBXIP) reduced MYC expression by METTL3-mediated c-myc proto-oncogene mRNA m6A modification, which inhibited the malignant progression of GC, as well as increased cell apoptosis [76]. This evidence concerns the gene METTL3 and gastric cancer.